











Osh proteins regulate COPII-mediated vesicular transport of
ceramide from the endoplasmic reticulum in budding yeast
Kentaro Kajiwara1, Atsuko Ikeda1, Auxiliadora Aguilera-Romero2, Guillaume A. Castillon3, Satoshi Kagiwada4,
Kentaro Hanada5, Howard Riezman3, Manuel Muñiz2 and Kouichi Funato1,*
ABSTRACT
Lipids synthesized at the endoplasmic reticulum (ER) are delivered to
the Golgi by vesicular and non-vesicular pathways. ER-to-Golgi
transport is crucial for maintaining the different membrane lipid
composition and identities of organelles. Despite their importance,
mechanisms regulating transport remain elusive. Here we report that
in yeast coat protein complex II (COPII) vesicle-mediated transport of
ceramide from the ER to the Golgi requires oxysterol-binding protein
homologs, Osh proteins, which have been implicated in lipid
homeostasis. Because Osh proteins are not required to transport
proteins to the Golgi, these results indicate a specific requirement for
the Osh proteins in the transport of ceramide. In addition, we provide
evidence that Osh proteins play a negative role in COPII vesicle
biogenesis. Together, our data suggest that ceramide transport and
sphingolipid levels between the ER and Golgi are maintained by two
distinct functions of Osh proteins, which negatively regulate COPII
vesicle formation and positively control a later stage, presumably
fusion of ceramide-enriched vesicles with Golgi compartments.
KEY WORDS: Oxysterol-binding protein, Ceramide, COPII,
Vesicular transport, Yeast
INTRODUCTION
Trafficking of newly synthesized lipids and proteins from the ER
is crucial and must be tightly regulated to maintain the specific
membrane composition and function of each organelle. Coat
protein complex II (COPII)-coated vesicles mediate transport of
both lipids and proteins to the Golgi compartment (Gillon et al.,
2012; Perry and Ridgway, 2005). In addition to COPII-dependent
vesicular transport, non-vesicular mechanisms are used for
delivery of lipids from the ER to other compartments (Lev,
2012; Perry and Ridgway, 2005; Prinz, 2010). The best-
characterized example of a lipid that is delivered to the Golgi
by non-vesicular mechanisms is ceramide (Perry and Ridgway,
2005; Prinz, 2010). It is converted in the Golgi to more complex
sphingolipids and is involved in the formation of sphingolipid-
and sterol-enriched domains that are proposed to be involved in
protein sorting and signaling (van Meer et al., 2008). In yeast, the
molecular mechanisms of COPII vesicle formation have been
extensively studied (Miller and Barlowe, 2010; Sato and Nakano,
2007) and our previous study showed that ceramides synthesized
de novo in the ER are transported to the Golgi by both COPII-
dependent vesicular transport and COPII-independent non-
vesicular transport (Funato and Riezman, 2001). Additionally
the COPII-independent pathway requires membrane contacts
between the ER and Golgi but not ATP (Funato and Riezman,
2001). To date the regulatory mechanisms of the COPII-
independent pathway remain largely unknown.
Oxysterol-binding protein (OSBP) and OSBP-related proteins
(ORPs) make up a conserved family of lipid-binding proteins that
are implicated in sterol homeostasis, phospholipid metabolism,
vesicular transport and regulation of non-vesicular ceramide
transport mediated by ceramide transport protein (CERT) (Beh
et al., 2012; Beh and Rine, 2004; de Saint-Jean et al., 2011; Fang
et al., 1996; Georgiev et al., 2011; Johansen et al., 2012; Perry and
Ridgway, 2006; Schulz et al., 2009; Stefan et al., 2011; Vihervaara
et al., 2011). Budding yeast lacks a CERT homolog, but expresses
ORPs. Osh4p, one of seven yeast ORPs (Osh1p–Osh7p) that share
overlapping essential functions, has binding sites for sterol and
phosphatidylinositol 4-phosphate (PtdIns4P) (de Saint-Jean et al.,
2011; Im et al., 2005). Moreover, it has been experimentally
demonstrated that Osh4p is involved in sterol transport between
membranes (de Saint-Jean et al., 2011). A sterol–PtdIns4P
exchange and control of their levels might be coupled to the
regulatory roles of Osh4p in post-Golgi vesicular transport
involving Sec14p and in polarized exocytosis (Beh et al., 2012;
Johansen et al., 2012). However, a recent study argued against a
role of Osh4p in sterol transfer (Beh et al., 2012; Georgiev et al.,
2011). Therefore, the exact function of Osh proteins is not yet clear
but they might be lipid sensors that control lipid and protein
metabolism (Stefan et al., 2011; Vihervaara et al., 2011) or
regulators of membrane contact site formation (Schulz et al., 2009)
or membrane composition and organization (Georgiev et al., 2011).
In this study, we show that COPII-dependent vesicular transport
of ceramide but not proteins from the ER to the Golgi requires Osh
proteins. We also report that, in addition to a function as positive
regulators, Osh proteins act as negative regulators of COPII vesicle
biogenesis. These findings show that vesicular ceramide transport
can be dissociated from protein transport suggesting either separate
vesicles or specific sorting mechanisms. Thus, sphingolipid levels
in cellular membranes could be regulated by ceramide vesicular
transport controlled by Osh proteins.
RESULTS
Osh proteins are needed for efficient ER to Golgi ceramide transport
To further understand the functions of the yeast Osh proteins in
lipid homeostasis, we analyzed the synthesis of complex
sphingolipids in a mutant strain (oshD osh4-1) that has a
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Fig. 1. See next page for legend.












temperature-sensitive osh4-1 allele of the OSH4 gene and
deletions of the other six OSH genes (Beh and Rine, 2004). In
this oshD osh4-1 mutant strain at both permissive and non-
permissive temperatures, incorporation of [3H]dihydrosphingosine
(DHS) into inositol phosphorylceramide subclass C (IPC-C), one
of the yeast complex sphingolipids, was reduced to half that of the
wild-type strain (Fig. 1A,C), despite the fact that the two strains
synthesized similar amounts of ceramides (Fig. 1B,C), which are
the direct precursors of IPCs. In oshD osh4-1, we also observed a
dramatically reduced incorporation of [3H]myo-inositol into IPC-C
(Fig. 1D,E). The IPC synthesis defects observed in the oshD
osh4-1 strain could be explained by either slower transport
kinetics of ceramide from the ER to the Golgi or a reduction in
the activity of IPC synthase. To discriminate between these two
possibilities we measured the IPC synthase activity in vivo as
described previously (Kajiwara et al., 2008). In this assay C2-
ceramide added exogenously to cells reaches the Golgi apparatus
through a diffusion-mediated or an endocytic route. There the IPC
synthase, Aur1p, modifies C2-ceramide into C2-IPC. We did not
find any significant difference in synthesis of C2-IPC in wild-type
and oshD osh4-1 cells (Fig. 1F,G), which suggested that oshD
osh4-1 cells are not compromised for IPC synthase activity. Thus,
we conclude that the IPC synthesis defect of oshD osh4-1 cells
results from a deficiency in ceramide transport.
Because Osh proteins are likely to play a role in transport of
ceramides from the ER to the Golgi, we wanted to determine
whether one of the Osh proteins or a specific subset is involved in
the ceramide transport. When mutants lacking one of the Osh
proteins were labeled with [3H]DHS, no significant difference
was found in the incorporation into IPC-C (supplementary
material Fig. S1A). Because mutant strains that have abnormal
sphingolipid metabolism exhibit altered sensitivity to inhibitors
of sphingolipid synthesis, such as aureobasidin A (AbA) (Epstein
et al., 2012; Kajiwara et al., 2012; Kajiwara et al., 2008; Malathi
et al., 2004), we measured growth of oshD deletion strains
on plates containing either AbA, which targets IPC synthase or
myriocin (Myr), which targets serine palmitoyltransferase
(Horvath et al., 1994; Nagiec et al., 1997). As reported
previously, the osh3D strain was resistant to Myr (Yano et al.,
2004), whereas it was hypersensitive to AbA (supplementary
material Fig. S1B). Interestingly, osh2D and osh4D strains
showed resistance to AbA. AbA and Myr had no or minimal
effects on the fitness of other deletion strains relative to WT. The
AbA resistance of osh2D and osh4D strains was suppressed by the
additional deletion of OSH3 (supplementary material Fig. S1B)
and osh2D AbA resistance was rescued by overexpression of
Osh4p (data not shown). These results suggest that Osh2p and
Osh4p act in a same pathway and Osh3p act antagonistically to
the Osh2p/Osh4p-dependent pathway, providing a link between
Osh2p/Osh4p and Osh3p function to maintain sphingolipid
homeostasis or to sense changes in sphingolipid levels.
The findings led us to assess the incorporation of [3H]DHS into
IPC in the double and triple mutants (supplementary material
Fig. S1A). Although no reductions were observed in the double
mutants, the osh2D osh3D osh4D triple mutant showed a
substantial decrease in IPC-C synthesis. Similar results were
obtained when cells were labeled with [3H]myo-inositol (data not
shown). We also found that the triple mutant synthesizes IPC-C at
rates markedly slower than the wild-type (Fig. 1H,J), despite
equal levels of ceramides (Fig. 1I,J), suggesting that Osh2p,
Osh3p and Osh4p are required for the efficient transport of
ceramide from the ER to the Golgi. Thus, it is likely that whereas
Osh2p/Osh4p and Osh3p have distinct functions, presumably in
sensing changes in sphingolipid levels, they have overlapping
functions in maintaining IPC synthesis. The osh2D osh3D osh4D
triple mutant had modest effects on mannosyl IPC (MIPC)
synthesis (Fig. 1H). This may be due to an increased activity in
converting IPC to MIPC, which might explain the enhanced
incorporation into MIPC that was observed in the oshD osh4-1
mutant at 25 C̊ (Fig. 1A). In addition, a steady-state metabolic
labeling with [3H]myo-inositol by a 1-hour pulse and a 20-hour
chase showed a decreased incorporation into complex
sphingolipids in the triple mutant (data not shown), consistent
with an increased sensitivity to both AbA and Myr
(supplementary material Fig. S1B).
Osh proteins are needed for vesicular transport of ceramides to the
Golgi compartment
In the budding yeast Saccharomyces cerevisiae, ceramide is
transported to the Golgi by both vesicular and non-vesicular
transport pathways (Funato and Riezman, 2001). Although the
mechanisms that regulate non-vesicular transport in yeast are
largely unknown, it was suggested that non-vesicular transport
occurs by an ATP-independent mechanism, through membrane
contact sites between the ER and Golgi (Funato and Riezman,
2001). Because Osh proteins appear to function at membrane
contact sites (Schulz et al., 2009; Stefan et al., 2011; Beh et al.,
2012), it is possible that Osh proteins might be needed for non-
vesicular transport of ceramide. To investigate this possibility, we
measured the incorporation of [3H]myo-inositol into IPC-C in the
osh2D osh3D osh4D strain under conditions that block vesicular
transport. If indeed Osh proteins regulate non-vesicular transport,
but not vesicular transport of ceramide, then the osh2D osh3D
osh4D mutant should show an additional reduction of IPC
synthesis by blocking vesicular trafficking. Unexpectedly, IPC
synthesis in the osh2D osh3D osh4D mutant, in comparison with
the wild type, was hardly affected by ATP depletion using NaN3
and NaF (Fig. 2A,B). This suggests that the supply of ceramide
Fig. 1. Osh proteins are required for efficient transport of ceramide
from the ER to the Golgi. (A–E) Cells were grown at either 25˚C or shifted to
37˚C for 20 minutes and labeled with [3H]DHS (A–C) or [3H]myo-inositol
(D,E) at the same temperature for 60 minutes. The labeled lipids were
extracted and applied to TLC plates that were developed with solvent system
II (A) or system I (D). Fractions containing ceramides in A, were collected by
scraping and the lipid extracts from the silica were analyzed by TLC using
solvent system III (B). Incorporation of [3H]DHS into IPC-C or ceramides
(Cer-A, -B and -C; C) and of [3H]myo -inositol into IPC-C (E) was quantified.
Incorporation was determined as a percentage of the total radioactivity. Data
are means 6 s.d. (n53) of three independent experiments. *P,0.05;
**P,0.01; compared with WT. (F,G) Cells were preincubated at 37˚C for
20 minutes and labeled with [3H]myo-inositol at 37˚C for 60 minutes in the
presence or absence of C2-ceramide. The labeled lipids were extracted and
analyzed by TLC using solvent system I (F). The incorporation into IPC-C
and C2-IPC was determined as a percentage of the total radioactivity (G).
(H–J) Cells were labeled with [3H]DHS at 25˚C for the indicated times. The
labeled lipids were extracted and analyzed by TLC using solvent system II
(H). Fractions containing ceramides in H were collected and the lipid extracts
were analyzed by TLC using solvent system III (I). The incorporation (%) into
IPC-C and ceramides were determined (J). PE, phosphatidylethanolamine;
PHS, phytosphingosine; PC, phosphatidylcholine; PI, phosphatidylinositol;
IPC-C, inositolphosphorylceramide subclasses C; MIPC, mannosyl
inositolphosphorylceramide; Cer-A, -B and -C, different ceramide species,
which were identified using mutants that are defective in the biosynthesis of
specific ceramide species and by chemical treatment as described
previously (Funato and Riezman, 2001; Haak et al., 1997); Lyso-PI,
lysophosphatidylinositol; M(IP)2C, mannosyl di(inositolphosphoryl)ceramide.












Fig. 2. See next page for legend.












for the remaining IPC synthesis in the osh triple mutant is brought
by non-vesicular transport, which is unaffected by ATP depletion;
therefore revealing that Osh proteins are involved in vesicular
transport of ceramide. Consistent with this, a triple deletion of
OSH2, OSH3 and OSH4 had no additive effect on the rates of IPC
or complex sphingolipid synthesis at non-permissive temperature
in sec12-4 (Fig. 2C,D) and sec18-20 (Fig. 2E,F) mutants, which
have defective vesicular transport (Funato and Riezman, 2001).
In addition, we found that CERT, which mediates non-
vesicular transfer of ceramide in mammalian cells (Hanada
et al., 2003), failed to complement the defects of both
incorporation into IPC-C in the osh2D osh3D osh4D cells
(supplementary material Fig. S2A,B) and growth at non-
permissive temperature in oshD osh4-1 cells (supplementary
material Fig. S2C), although it could be due to differential
substrate specificities of Osh proteins and CERT in ceramide
transfer. Osh4p also failed to complement the defect of
sphingomyelin synthesis in a Chinese hamster ovary (CHO)
cell line LY-A mutant (supplementary material Fig. S2D), which
has a missense mutation in the CERT (Hanada et al., 2003).
Osh proteins contribute in a SAC1-independent manner to
IPC synthesis
Osh proteins stimulate Sac1p phosphoinositide phosphatase
activity (Stefan et al., 2011). Because deletion of SAC1 reduces
complex sphingolipid levels (Brice et al., 2009), Osh protein-
mediated ceramide transport may be driven by a Sac1p-dependent
process. We found, however, that overexpression of Sac1p
rescued the IPC synthesis defect and PtdIns4P accumulation as
observed in sac1D cells (supplementary material Fig. S3A), but
not the IPC synthesis defect in osh2D osh3D osh4D cells
(supplementary material Fig. S3B), suggesting that Osh proteins
contribute in a SAC1-independent manner to IPC synthesis.
Osh proteins are not required for vesicular transport of proteins to the
Golgi compartment
If Osh proteins are needed for efficient vesicular transport
of ceramide from the ER, then we predict that deletion of
OSH genes should affect the ER-to-Golgi transport of
glycosylphosphatidylinositol-anchored proteins (GPI-APs),
because we previously proposed that ceramides and GPI-APs
are co-transported in the same vesicles from the ER in yeast
(Kajiwara et al., 2008). However, the triple deletion of OSH2,
OSH3 and OSH4 had no effect on the maturation of the GPI-AP,
Gas1p, consistent with normal transport to the Golgi (Fig. 2G).
Biogenesis of a non-GPI-AP, carboxypeptidase Y (CPY), was
also unaffected in osh2D osh3D osh4D cells (Fig. 2G). These
results are consistent with a previous study that used strains
lacking all OSH (Beh and Rine, 2004), and provide further
evidence that Osh proteins are not required for vesicular transport
of proteins from the ER.
Osh proteins function as negative regulators of vesicle budding from
the ER
Although Osh proteins do not have an essential function in
protein trafficking, they might act as negative regulators of
protein transport. Indeed, deletion of OSH4 has been reported to
suppress the Golgi secretory defect in sec14 mutant cells (Fang
et al., 1996). To investigate the possibility that Osh proteins may
regulate other secretory processes, we created strains carrying
multiple deletions of OSH genes in different sec mutants and
examined the growth phenotypes at various temperatures.
Consistent with previous studies (Fang et al., 1996), deletions
of OSH4 were able to suppress the lethality associated with a
mutation in the SEC14 gene (Fig. 3A). Interestingly, a triple
deletion of OSH2, OSH3 and OSH4 and, less efficiently, a double
deletion of the OSH2 and OSH4 rescued the severe growth defect
of sec12-4 mutant cells at semi-permissive temperatures (33 C̊
and 35 C̊). A partial rescue was also seen in sec23-1 or sec16-2
mutant cells lacking three OSH genes (Fig. 3B); however, rescue
was not observed in other sec mutant (sec31-1, sed5-1, sec18-20,
ret1-1 and sec35-1) strains. Because Sec12p regulates the
initiation of COPII vesicle budding from the ER and Sec23p is
a component of the COPII vesicle coat (Miller and Barlowe,
2010; Sato and Nakano, 2007), our data strongly suggest that Osh
proteins function as negative regulators of vesicle budding from
the ER.
To assess more directly the negative role of Osh proteins in
COPII vesicle budding, we first analyzed the maturation of cargo
proteins, Gas1p and CPY. We found that the delayed kinetics of
maturation of Gas1p and CPY in sec12-4 mutant cells were
partially suppressed by the triple deletion of OSH2, OSH3 and
OSH4 at a semi-permissive temperature (33 C̊; Fig. 4A), whereas
no suppression was observed when pulse–chase experiments were
carried out at higher temperature (35 C̊; data not shown). Next,
we examined the localization of Rer1p, which is a retrieval
receptor for ER membrane proteins and is recycled between the
ER and Golgi but is localized in the Golgi at steady-state (Sato
et al., 2001). When the ER to Golgi anterograde transport is
blocked by the sec12-4 mutation, GFP–Rer1p accumulates in the
ER (Sato et al., 2001). If anterograde transport by COPII vesicles
is negatively regulated by Osh proteins, the osh2D osh3D osh4D
sec12-4 quadruple mutant should not accumulate GFP–Rer1p in
the ER, but should instead accumulate it in the Golgi. Indeed,
upon a shift to semi-permissive temperatures (35 C̊), the sec12-4
mutant caused an increase in the number of cells with GFP–Rer1p
localized to the ER only (nuclear ring staining) but not to the
Golgi (punctate staining). The osh2D osh3D osh4D sec12-4
mutant showed no significant impact on the localization of GFP–
Rer1p, in comparison with those of the strains at permissive
temperature (25 C̊; Fig. 4B,C). These results suggest that the
anterograde transport defects in the sec12-4 mutant are at least
partially rescued by the absence of Osh2p, Osh3p and Osh4p.
Because Sec12p seems to be implicated in the biogenesis of ER
exit sites (ERES), where budding of the COPII vesicles occurs
(Castillon et al., 2009; Shindiapina and Barlowe, 2010), we next
investigated whether deletion of OSH genes affects the
Fig. 2. Osh proteins have a cargo-specific function in vesicular
transport from the ER. (A,B) Cells labeled with [3H]myo-inositol at 4˚C for
60 minutes were subjected to ATP depletion (NaF and NaN3 treatment) and
then chased at 25˚C for 60 minutes. The labeled lipids were extracted and
analyzed by TLC using solvent system I (A). The incorporation into IPC-C
was determined as a percentage of the total radioactivity minus the
incorporation (%) in non-chased cells (B). (C–F) Cells grown at 25˚C were
shifted to 37˚C for 20 minutes and labeled with [3H]myo-inositol at 37˚C for
60 minutes. The labeled lipids were extracted and analyzed by TLC using
solvent system I (C,E). The incorporation (%) into IPC-C and into total
complex sphingolipids [IPC-C, MIPC and M(IP)2C] were determined (D,F).
Data in B and D are means 6 s.d. (n53) of three independent experiments.
*P,0.05; n.s., not significant. (G) Cells were labeled with [35S]methionine for
5 minutes and chased at 25˚C for the indicated times. Proteins were
immunoprecipitated, resolved by SDS-PAGE, and analyzed with a
phosphoimager. p1 and p2, ER and Golgi forms of CPY, respectively; p, ER
form of Gas1; m, mature form of CPY or Gas1.












localization of the ERES marker Sec13p in sec12-4 mutant cells.
The number of Sec13p–mCherry puncta per sec12-4 mutant cell
was significantly (P,0.01) reduced (Fig. 4D,E), whereas the
number of cells with large dots of Sec13p–mCherry was strongly
increased (Fig. 4D,F) even at a semi-permissive temperature
(30 C̊). These relatively mild phenotypes observed at 30 C̊ were
also rescued by the deletion of OSH2, OSH3 and OSH4 (Fig. 4D–
F), suggesting that Osh proteins negatively regulate the
organization of ERES and thus the vesicle budding from the ER.
DISCUSSION
Our results support the view that whereas Osh proteins play a role
in the positive regulation of vesicular transport of ceramide from
the ER to the Golgi, they negatively regulate COPII-mediated ER
export of cargoes. How Osh proteins regulate these processes is
unknown. However, our observations showed that loss of either
Scs2p alone or both Scs2p and Scs22p, which localize to ER and
bind to FFAT (two phenylalanines in an acidic tract) motifs of
Osh proteins to target them to the ER (Loewen et al., 2003),
did not affect the synthesis of IPC-C (supplementary material
Fig. S4A,B), whereas the loss did result in partial suppression of
the temperature-sensitive growth phenotype of sec12-4 mutant
(supplementary material Fig. S4C). We therefore propose the
following model for the two roles of Osh proteins (Fig. 5A).
When bound to Scs2p and/or Scs22p and/or the ER, Osh proteins
negatively regulate cargo sorting or vesicle scission at ER exit
sites. When Osh proteins dissociate from the ER, they positively
regulate or facilitate the targeting of ceramide-enriched vesicles
to the Golgi, where they are converted into IPC.
In budding yeast, ceramides and GPI-APs mutually regulate
their vesicular transport from the ER to the Golgi (Horvath et al.,
1994; Kajiwara et al., 2008; Watanabe et al., 2002), leading to the
proposal that ceramides and GPI-APs are co-transported in the
same vesicles budding from the ER (Kajiwara et al., 2008).
Fig. 3. Triple deletion of OSH2,
OSH3 and OSH4 suppresses the
temperature-sensitive growth
defects of sec12-4 and sec23-1
mutants. (A,B) Fivefold serial
dilutions of cells were spotted onto
SD plates and the plates were then
incubated at the indicated
temperatures for 3 days.












Because vesicular transport of ceramide from the ER is mediated
by COPII-coated vesicles (Funato and Riezman, 2001), if
ceramides are not directly recognized by COPII coat proteins,
other cargo–cargo receptor complexes that are recognized
by COPII coat proteins must be incorporated at the ERES
where ceramide-rich vesicles are formed. The p24 proteins
have been proposed to act as cargo receptors for GPI-APs to
be sorted into COPII vesicles (Castillon et al., 2011; Gillon et al.,
Fig. 4. Triple deletion of OSH2, OSH3 and OSH4 significantly rescues the transport defects in the sec12-4 mutant. (A) Cells were labeled with
[35S]methionine for 5 minutes and chased at 33˚C for the indicated times. Proteins were immunoprecipitated, resolved by SDS-PAGE, and analyzed with a
phosphoimager. (B,C) Cells expressing GFP–Rer1p were treated with cycloheximide (0.2 mg/ml) at 25˚C for 20 minutes and then incubated at 25˚C or 35˚C. After
60 minutes, localization of GFP–Rer1p was observed by fluorescence microscopy and the images were acquired within 10 minutes (B). The subcellular localization
of GFP–Rer1p was quantified by counting the number of cells that displayed nuclear ring staining (ER), punctate staining (Golgi) or both (C). More than 200 cells
were evaluated for each sample per experiment, and data are means 6 s.d. (n53) of three independent experiments. *P,0.05. (D–F) Cells expressing Sec13p–
mCherry were incubated at the indicated temperatures for 60 minutes and observed by fluorescence microscopy (D). Fluorescence micrographs acquired within
10 minutes were used to quantify the number of fluorescent dots per cell (E) and the number of cells with large dots (F). At least 30 cells were evaluated for
each sample per experiment, and data are means 6 s.d. (n53) of three independent experiments. **P,0.01; ***P,0.001. Scale bars: 10 mm.












2012). In the case in which ceramides and GPI-APs are
incorporated into the same vesicles, it is tempting to consider
the possibility that Osh proteins may promote concentration of
ceramide at ERES (Fig. 5B). This could lead to an excess
concentration of ceramides at Sec12p-deficient ERES that
interferes with the incorporation of GPI-APs and the cargo-
protein-mediated COPII assembly. In cells lacking Osh proteins,
a sufficient COPII assembly to form vesicles containing cargo
proteins, even without Sec12p, may be achieved by blocking
concentration of ceramides at ERES. According to this
partitioning model, double deletions of OSH2 and OSH4 or
SCS2 and SCS22 would cause decreased IPC synthesis because
they have sufficient ability to rescue the temperature-sensitive
growth defect of sec12-4 mutant (Fig. 3A; supplementary
material Fig. S4C). However, the osh2D osh4D and scs2D
scs22D mutants did not show any decrease in IPC synthesis
(supplementary material Fig. S1A; Fig. S4A,B). Additionally, the
partitioning model cannot explain adequately why deletion of
OSH2, OSH3 and OSH4 rescues not only the GPI-AP transport
defect, but also the non-GPI-AP transport defects of sec12-4
mutant because the transport of ceramides and GPI-APs do not
seem to be coupled to that of non-GPI-APs (Kajiwara et al.,
2008).
Although we cannot entirely rule out the possibility that Osh
proteins facilitate the packaging of ceramide into GPI-APs-
enriched COPII vesicles, and other models are also conceivable, a
specific requirement for Osh proteins in ceramide trafficking
suggests that ceramide-enriched vesicles could be distinct from
those containing GPI-APs (Fig. 5A). This raises the following
questions: what is the role of the specific vesicle that contains
Fig. 5. Models for the function of Osh proteins
in vesicular traffic from the ER. See Discussion
for further explanation.












ceramides and the role of Osh proteins in ceramide delivery to the
Golgi compartment? In this connection, it is interesting to note
that the IPC synthase catalytic subunit, Aur1p, is localized mainly
to the medial-Golgi but not the cis-Golgi (Levine et al., 2000).
Because the domains of Osh proteins such as pleckstrin homology
domain, FFAT and ORP-related domain motifs have the ability to
form the contact sites between the ER and the Golgi (Beh et al.,
2012; Schulz et al., 2009; Vihervaara et al., 2011), Osh proteins
may serve as tethering factors to target ER-derived ceramide
vesicles directly to the medial-Golgi or as bridging proteins to
facilitate ceramide delivery by forming unique regions of the ER
membrane closely apposed to the medial-Golgi, reducing the
distance between the organelles. Otherwise Osh proteins could
generate a membrane environment leading to specific targeting of
ceramide-enriched vesicles because of the ability of some Osh
proteins to exchange lipids between lipid bilayers (Beh et al.,
2012; Schulz et al., 2009; Vihervaara et al., 2011). Although this
unconventional process and its mechanistic basis remain to be
elucidated, it may play a crucial role in maintaining the
metabolism and distribution of sphingolipids, which can be
involved in diverse cellular functions such as signal transduction,
membrane trafficking and other lipid metabolism.
The reason for specific lipid requirements in efficient transport
of GPI-APs also remains unknown, but it is conceivable that a
specific lipid environment on Golgi membranes may be required
for docking and fusion of GPI-AP-enriched vesicles, or that the
role of ceramides in GPI-AP transport is solely in anchor
remodeling (Horvath et al., 1994; Watanabe et al., 2002).
Our findings that deletion of the OSH2, OSH3 and OSH4 genes
rescues the phenotypes of sec12-4 mutant cells are surprising.
Given that Osh2p and Osh3p but not Osh4p have a FFAT motif
(Loewen et al., 2003), that the suppressive effect of scs2 mutation
on growth of sec12-4 is enhanced by OSH4 deletion
(supplementary material Fig. S4C), which is specific to sec12-4
(supplementary material Fig. S4D) and dependent on the
association with the FFAT motif (supplementary material
Fig. S4E), it is probable that the bypass of SEC12 function by
inactivation of three OSH genes involves both Scs2p-Scs22p-
FFAT-dependent and -independent modes (Fig. 5A). According
to this and the model for two roles of Osh proteins in vesicle
budding and targeting, the scs2D scs22D mutant would have
enhanced ceramide transport. However, this does not seem to be
the case (supplementary material Fig. S4A,B). Osh4p does not
have FFAT motifs and it may be associated with an unidentified
ER-resident protein. Thus, cytosolic Osh4p might be necessary to
stimulate the targeting of ceramide-enriched vesicles to the Golgi
compartment.
Mechanistic details of the bypass of SEC12 function are
unknown; however, there are several possibilities that can be
considered. One possibility is that the bypass of SEC12 function
could result from reduced levels of GPI-APs as the membrane-
deforming ability of the COPII coats might depend on the local
concentration of luminal-asymmetric membrane cargoes (Čopič
et al., 2012). But, this seems unlikely because triple null
mutations (osh2D osh3D osh4D) did not impact Gas1p
maturation and because the temperature-sensitive phenotype of
the sec12-4 mutant was not bypassed by loss of ERI1, which
functions in GPI synthesis (data not shown). Another possibility,
that activation of unfolded protein response, which reduces the
protein load in the ER lumen (Chang et al., 2004), contributes to
the bypass of SEC12 function is also unlikely. Indeed, we found
that unfolded protein response-dependent expression of a yeast
chaperone, Kar2p was not affected in osh2D osh3D osh4D cells
(data not shown).
COPII-mediated ER export, from coat recruitment to vesicle
scission, depends on the membrane composition, not only of
proteins but also lipids (Blumental-Perry et al., 2006; Farhan and
Rabouille, 2011; Miller and Barlowe, 2010; Shindiapina and
Barlowe, 2010). Yeast cells lacking Osh proteins or both Scs2p
and Scs22p accumulate PtdIns4P (Stefan et al., 2011). It has been
reported that in mammalian cells, PtdIns4P at ERES is required
to regulate membrane deformation at ERES and promote COPII-
mediated ER export (Blumental-Perry et al., 2006). However, the
analysis of mutants revealed that alterations in PtdIns4P
metabolism did not impact ER export in in vitro budding yeast
(Audhya et al., 2000; Lorente-Rodrı́guez and Barlowe, 2011).
Consistent with this, the results from a previous study (Cleves
et al., 1989) and this study (supplementary material Fig. S3C)
showed that the temperature-sensitive growth defect of the
sec12-4 mutant was not suppressed by SAC1 mutations,
suggesting that the ability of oshD to suppress sec12-4 mutant
phenotypes does not depend on Sac1p.
In addition, it is unlikely that the suppression of the protein
transport defect of the sec12-4 by deletions of OSH genes is due
to an altered sphingolipid metabolism. Two observations support
this. The osh2D osh4D double and osh2D osh3D osh4D triple
deletions that can suppress the growth defect of sec12-4 had
different effects on sensitivity to AbA and on IPC synthesis,
suggesting that the ability to suppress does not correlate with the
changes in sphingolipid levels. We also found that the growth
phenotype of the sec12-4 mutant was not rescued by AbA
(0.05 mg/ml; data not shown) or Myr (0.1 mg/ml; data not shown)
or treatment by supplementation with ergosterol (100 mg/ml; data
not shown). These results imply that neither altered sphingolipids
nor sterols contribute to the bypass of SEC12 function.
Furthermore, our findings that scs2D but not osh2D osh3D
osh4D mutant is an inositol auxotroph (supplementary material
Fig. S4F) indicate that the ability of OSH deletion to rescue
sec12-4 phenotypes might be not due to an impaired regulation of
phospholipid synthesis.
Although the current study does not completely elucidate how
Osh proteins regulate COPII-mediated ER export, they might act
as a sensor to control the GTP–GDP cycle of the small GTPase
Sar1p, which is regulated by the guanine nucleotide exchange
factor, Sec12p and the GTPase-activating protein, Sec23p. This
idea is consistent with our results showing that loss of Osh
proteins can rescue both temperature-sensitive phenotypes of
sec12-4 and sec23-1 mutants. In addition to functioning in the
assembly and disassembly of the COPII coat, the GTP–GDP
cycle of Sar1p seems to be involved in vesicle scission (Sato and
Nakano, 2007). The continual GTP–GDP cycles would lead to an
efficient but also incorrect vesicle scission. Thus, Osh proteins
possibly retard the abnormal cycles to prevent disordered vesicle
scission that forms vesicles carrying mis-sorted cargoes. The
potential involvement of the GTP–GDP cycle in cargo selection
and concentration has been proposed (Miller and Barlowe, 2010;
Sato and Nakano, 2007), so it might also be that Osh proteins
function to avoid the excess or improper loading of cargoes such
as mis-sorted, misfolded and ER-resident proteins into the
vesicles, perhaps coordinated with Sec16p, which regulates the
GTP–GDP cycle of Sar1p and organization of ERES (Kung et al.,
2012; Miller and Barlowe, 2010). However, our experiments
indicated that triple deletion of OSH2, OSH3 and OSH4 was not
able to rescue cytoplasmic mislocalization of Sar1p–mCherry in












sec12-4 mutants (data not shown). This suggests that Osh proteins
are not involved in regulating the GTP–GDP cycle of Sar1p
because Sar1p localization is dependent on the nucleotide-
binding state (Yorimitsu and Sato, 2012). Thus, it is possible
that Osh proteins play a role in coat stabilization after GTP
hydrolysis.
Finally, we favor the model with two distinct functional roles
of Osh proteins in vesicular transport of ceramide to the Golgi
and COPII-mediated ER export. As ceramides might be sorted
into COPII vesicles different from those for proteins, and targeted
to the Golgi compartments by a distinct molecular mechanism
that involves Osh proteins, further study of the mechanism will
provide new insights not only into the sorting process at ERES




All yeast strains used in this study are listed in supplementary material
Table S1. Yeast strains were generated either by PCR-based one-step
gene replacement (Baudin et al., 1993) or by crossing, sporulation and
subsequent dissection of the spores. Deletion strains were confirmed by
PCR. C-terminal triple hemagglutinin (HA)-tagging of Osh4p (Osh4p-
36HA) was carried out by a PCR-based method to generate the
FKY146 strain from FKY136 as described previously (Levine et al.,
2000). DNA cloning techniques, Escherichia coli transformation and
site-directed mutagenesis were performed as described previously
(Kagiwada and Hashimoto, 2007; Sambrook et al., 1989) and by
standard procedures. The plasmid for expression of Osh4p-36HA was
constructed as follows. The BamHI–SalI fragment containing the open
reading frame of OSH4-36HA was amplified by PCR using the FKY146
strain as template and cloned into pRS415ADH (CEN, LEU2), which
contains the ADH1 promoter and the CYC1 terminator, to obtain
pRS415ADH-OSH4-36HA (FKP161). To generate plasmid pcDNA-
OSH4-36HA (FKP117), the BamHI–SalI fragment containing
OSH4-36HA from pRS415ADH-OSH4-36HA was inserted into the
BamHI–XhoI sites of pcDNA3.1(+)Neo. The plasmid to express HA-
tagged human CERT (HA-hCERT) in yeast was made from pcDNA-HA-
hCERT (Kudo et al., 2008). The EcoRI–XhoI fragment containing
HA-hCERT was inserted into pRS414GPD (which contains the TDH3
promoter) and subcloned into SmaI–XhoI sites of pRS415ADH to obtain
pRS415ADH-HA-hCERT (FKP171). The XbaI–XhoI fragments
containing OSH4-36HA from FKP161 and HA-hCERT from FKP171
were also subcloned into XbaI–XhoI sites of pRS416GPD to obtain
pRS416GPD-OSH4-36HA (FKP353) and pRS416GPD-HA-hCERT
(FKP353), respectively. A LEU2 plasmid expressing Sec13p-mCherry
(YCplac111-Sec13-mCh) was constructed as described previously
(Castillon et al., 2011), by PCR using the primers 59-gggatatca-
ggaggcttccgagattttgg-39 and 59-gggatatcctcgcaggtctgcagcgaggcgcc-39
followed by enzymatic digestion with EcoRV and ligation. To generate
LEU2 plasmids expressing wild-type Scs2 (pRS415-SCS2), mutant scs2
K[80/84/119/122]A (pRS415-scs2-K[80/84/119/122]A) and L84D/L86A
(pRS415-scs2-L84D/L86A) under its own promoter, the fragments
containing wild-type SCS2 from YCplac33-SCS2 (pKY151) (Kagiwada
et al., 1998) and mutant scs2 from YCplac33-mutant scs2 vectors,
respectively, which were constructed as described previously (Kagiwada
and Hashimoto, 2007), were subcloned into HindIII–BamHI sites of
pRS415. A LEU2 plasmid expressing GFP-tagged Rer1p (pRS415-GFP-
RER1) was constructed from pSKY5-RER1 (Sato et al., 2001), which
was kindly provided by A. Nakano (RIKEN, Japan). The BamHI–SalI
fragment containing the TDH3 promoter, the open reading frame of GFP-
RER1 and the CMK1 terminator were subcloned into BamHI–SalI sites of
pRS415. The pRS425-SAC1 plasmid was constructed by subcloning
SAC1 as a 2.09-kb KpnI–SacI genomic DNA fragment that includes the
SAC1 promoter and SAC1 gene from YEplac195-SAC1 (Kagiwada et al.,
1996) into pRS425.
Drug and temperature sensitivity assays
Drug and temperature sensitivity assays were performed as described
previously (Kajiwara et al., 2012). Briefly, cells were grown to log phase
at 25 C̊ in synthetic dextrose (SD) minimal medium (Funato et al., 2003).
The next day cells at an initial concentration of OD600 nm51 were serially
diluted 1:5 in sterile water. Eight microliters of each 5-fold serial dilution
was spotted onto SD plates containing the indicated concentrations of
Myr (BIOMOL Research Laboratories Inc., PA, USA) or AbA (Takara
Bio Inc., Shiga, Japan) and incubated at 25 C̊ for 3 days. Temperature
sensitivity was carried out by spotting diluted yeast cultures on SD plates
supplemented with the appropriate nutrients to select for plasmids and by
incubating at the indicated temperatures.
Lipid labeling
Labeling of yeast sphingolipids with [3H]myo-inositol (PerkinElmer Life
Sciences) or [3H]DHS (American Radiolabeled Chemical Inc.) was
performed as described previously (Kajiwara et al., 2008). Cells grown
overnight in SD medium at 25 C̊ were resuspended in SD without inositol
for labeling with [3H]myo-inositol, or SD medium for labeling with
[3H]DHS, preincubated at the indicated temperatures for 20 minutes, and
then labeled with 10 mCi [3H]myo-inositol or 4 mCi [3H]DHS at the same
temperature used for preincubation, for the indicated times. If present,
50 mM C2-ceramide (Avanti Polar Lipids, Inc. AL, USA) was added
before the labeling. For the energy deprivation experiments (Funato and
Riezman, 2001), cells were preincubated on ice for 30 minutes and were
pulse labeled with 20 mCi of [3H]myo-inositol on ice for 60 minutes.
After addition of 100 mg/ml cold myo-inositol, 10 mM NaF and 10 mM
NaN3 were added to the cells followed by incubation on ice for
10 minutes, the energy-deprived cells were chased by adding ten times
the volume of SD medium containing myo-inositol (10 mg/ml), at 25 C̊
for 60 minutes. The reaction was stopped by placing the mixture on ice.
The cells were washed with cold water and subjected to lipid extraction,
and if necessary, to mild alkaline hydrolysis to deacylate
glycophospholipids as described previously (Kajiwara et al., 2008).
The pooled organic phases were desalted by partitioning with n-butanol,
and lipids were dried under nitrogen. Radiolabeled lipids were analyzed
by thin layer chromatography (TLC) using solvent system I,
chloroform:methanol:0.25% KCl (55:45:10, v/v) for lipids labeled
with [3H]myo-inositol, solvent system II: chloroform:methanol:4.2
N-ammonium hydroxide (9:7:2, v/v) for lipids labeled with [3H]DHS,
and were quantified using the FLA-7000 system (Fujifilm). For ceramide
analysis, the lipids labeled with [3H]DHS were separated on TLC plates
using solvent system II. Subsequently, fractions containing ceramides,
which are ,2–3 cm from the top of the TLC plates (Funato and Riezman,
2001; Kajiwara et al., 2012), were collected by scraping and eluting with
chloroform:methanol (1:1, v/v), and were analyzed by TLC using solvent
system III: chloroform:methanol:acetc acid (190:9:1, v/v), as described
previously (Cremesti and Fischl, 2000; Haak et al., 1997).
Metabolic labeling of CHO cells with [14C]serine was performed as
described previously (Kawano et al., 2006). Briefly, cell lines CHO-K1
and LY-A, a CHO-KI-derived mutant cell line defective in ER-to-Golgi
transport of ceramide (Hanada et al., 2003), which was transiently
transfected with plasmids using Lipofectamine Plus2 reagent
(Invitrogen) were grown and incubated in Nutridoma medium
containing [14C]serine at 37 C̊ for 2 hours. After two washes with cold
phosphate-buffered saline, labeled lipids were extracted from the cells
and were analyzed by TLC using solvent system IV: methyl acetate:n-
propanol:chloroform:methanol:0.25% KCl (25:25:25:10:9, v/v).
Protein transport assays
Pulse–chase analysis of Gas1p and CPY was carried out exactly as
described (Horvath et al., 1994; Watanabe et al., 2002). The pRS415-
GFP-RER1 plasmid carrying GFP-tagged Rer1p was used for a
trafficking assay of a cargo receptor. Yeast strains transformed with
pRS415-GFP-RER1 were treated with cycloheximide (0.2 mg/ml) at
25 C̊ for 20 minutes prior to incubation at the indicated temperatures for
60 minutes, and observed by fluorescence microscopy (Olympus BX51,
Tokyo, Japan). In order to observe ER exit sites where newly synthesized












proteins are packaged into budding COPII vesicles, cells were
transformed with YCplac111-Sec13-mCh and were observed using a
AXIOZ1 microscope as described previously (Castillon et al., 2011).
Immunoblotting
Protein extraction from yeast, SDS-PAGE and western blotting were
performed as described previously (Schönbächler et al., 1995). For
protein extraction from CHO cells, the cells cultured in dishes, were
washed with phosphate-buffered saline and harvested in buffer A
(40 mM Tris-HCl, pH 7.4, 180 mM NaCl and 1 mM EDTA) by
scraping (Tomishige et al., 2009). After precipitation by centrifugation,
cells were suspended in buffer B [10 mM HEPES-NaOH, pH 7.4,
250 mM sucrose, 1 mM EDTA and protease inhibitor cocktail
(Complete; Roche Diagnostics)], and lysed by sonication. The cell
lysate was subjected to SDS-PAGE and western blotting. Blots were
probed with a rat monoclonal antibody against HA (3F10) and a
peroxidase-conjugated affinity-purified anti-rat IgG antibody.
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